BRPI0408972A - composto, formulação, uso de um composto, e, processo para a preparação de um éster de polioxialquileno glicol - Google Patents

composto, formulação, uso de um composto, e, processo para a preparação de um éster de polioxialquileno glicol

Info

Publication number
BRPI0408972A
BRPI0408972A BRPI0408972-3A BRPI0408972A BRPI0408972A BR PI0408972 A BRPI0408972 A BR PI0408972A BR PI0408972 A BRPI0408972 A BR PI0408972A BR PI0408972 A BRPI0408972 A BR PI0408972A
Authority
BR
Brazil
Prior art keywords
compound
preparation
polyoxyalkylene glycol
polyoxyalkylene
fatty acid
Prior art date
Application number
BRPI0408972-3A
Other languages
English (en)
Inventor
Christian Von Corswant
Karl Hult
Erik Soederlind
Fredrik Viklund
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of BRPI0408972A publication Critical patent/BRPI0408972A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen
    • C08G65/332—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof
    • C08G65/3322—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof acyclic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/62—Carboxylic acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Polymers & Plastics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyethers (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)

Abstract

"COMPOSTO, FORMULAçãO, USO DE UM COMPOSTO, E, PROCESSO PARA A PREPARAçãO DE UM éSTER DE POLIOXIALQUILENO GLICOL". Tensoativos novos não iónicos na forma de derivados de ácido hidróxi graxo polioxialquileno glicol ou derivados de ácido hidróxi graxo polioxialquileno glicol monoalquilado tendo uma cadeia de polioxialquileno/ alquil polioxialquileno com um comprimento de cadeia de 25 - 455 unidades de repetição e um substituinte especificado na posição hidroxila do ácido hidróxi graxo especificado, de acordo com a fórmula geral (I) onde, por exemplo, R~ 1~, é metila, R~ 2~ é acila, alquila, ou alquenila C~ 14~-C~ 22~ opcionalmente substituido, R~ 3~ é etileno, x é 2 - 12, y é 7 17, (x + y) é 3 - 19 e z é 25 - 57; preparado vantajosamente através do envolvimento de um processo enzimático, as formulações compostas dos mesmos, o seu uso como solubilizante em um processo envolvendo uma enzima hidrolítica para a preparação dos mesmos.
BRPI0408972-3A 2003-04-14 2004-04-13 composto, formulação, uso de um composto, e, processo para a preparação de um éster de polioxialquileno glicol BRPI0408972A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0301119A SE0301119D0 (sv) 2003-04-14 2003-04-14 New non-ionic surfactants for solubilizing poorly soluble molecules
PCT/SE2004/000572 WO2004089869A1 (en) 2003-04-14 2004-04-13 New non-ionic surfactants for solubilizing poorly soluble molecules

Publications (1)

Publication Number Publication Date
BRPI0408972A true BRPI0408972A (pt) 2006-04-04

Family

ID=20291043

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0408972-3A BRPI0408972A (pt) 2003-04-14 2004-04-13 composto, formulação, uso de um composto, e, processo para a preparação de um éster de polioxialquileno glicol

Country Status (17)

Country Link
US (1) US7491836B2 (pt)
EP (1) EP1615874B1 (pt)
JP (1) JP4589917B2 (pt)
KR (1) KR101091324B1 (pt)
CN (1) CN1774414B (pt)
AU (1) AU2004228602B2 (pt)
BR (1) BRPI0408972A (pt)
CA (1) CA2521612C (pt)
ES (1) ES2445821T3 (pt)
HK (1) HK1089747A1 (pt)
IL (1) IL171058A (pt)
MX (1) MXPA05010893A (pt)
NO (1) NO20055331L (pt)
NZ (1) NZ542752A (pt)
SE (1) SE0301119D0 (pt)
WO (1) WO2004089869A1 (pt)
ZA (1) ZA200508247B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090280429A1 (en) * 2008-05-08 2009-11-12 Xerox Corporation Polyester synthesis
GB201115634D0 (en) * 2011-09-09 2011-10-26 Univ Liverpool Compositions of lopinavir
US20150133551A1 (en) 2012-05-03 2015-05-14 Beth Israel Deaconess Medical Center, Inc. Lipids That Increase Insulin Sensitivity And Methods Of Using The Same
EP2972399B1 (en) 2013-03-15 2020-09-02 Beth Israel Deaconess Medical Center, Inc. Lipids that increase insulin sensitivity and methods of using the same
US9284583B2 (en) * 2014-07-16 2016-03-15 Eastman Chemical Company Enzyme-catalyzed polyoxyalkylene esters
WO2017214527A1 (en) 2016-06-10 2017-12-14 Beth Israel Deaconess Medical Center, Inc. Fatty acid esters of hydroxy fatty acids (fahfas) for use in the treatment of type 1 diabetes
CN107664676A (zh) * 2016-07-29 2018-02-06 中国石油化工股份有限公司 基于增粘型乳液增溶水速率分析方法
KR20210054523A (ko) * 2018-09-05 2021-05-13 론자 광저우 난샤 리미티드 폴리옥시에틸렌 1,4-소르비탄 지방산 에스테르의 제조 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2911241A1 (de) * 1979-03-22 1980-10-02 Basf Ag Alkoxylierte fettsaeuren, verfahren zu deren herstellung und ihre anwendung als loesungsvermittler
JPS5969135A (ja) 1982-10-12 1984-04-19 Nippon Oil & Fats Co Ltd 可溶化または乳化剤
JPS61187795A (ja) * 1985-02-15 1986-08-21 Dai Ichi Kogyo Seiyaku Co Ltd ポリグリセリン脂肪酸エステルの製造法
CA2231404C (en) * 1994-11-03 2009-02-17 Arzneimittelwerk Dresden Gmbh Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability, and process for producing them
JP3533043B2 (ja) * 1995-06-19 2004-05-31 三菱化学株式会社 ポリグリセリン脂肪酸エステルの曇点測定方法、該方法を用いる物性評価及び製造方法。
FR2746106B1 (fr) * 1996-03-15 1998-08-28 Combustible emulsionne et l'un de ses procedes d'obtention
JP3610509B2 (ja) * 1996-03-26 2005-01-12 サンノプコ株式会社 消泡剤
DE19622214C2 (de) * 1996-06-03 2000-09-28 Cognis Deutschland Gmbh Verwendung von Hydroxycarbonsäureestern
DE19851777A1 (de) * 1998-11-10 2000-05-11 Basf Ag Verwendung von Estern oder Amiden hydroxylierter Carbonsäuren als Solubilisatoren

Also Published As

Publication number Publication date
HK1089747A1 (en) 2006-12-08
JP4589917B2 (ja) 2010-12-01
CN1774414B (zh) 2010-12-08
WO2004089869A1 (en) 2004-10-21
MXPA05010893A (es) 2005-11-25
NO20055331L (no) 2006-01-16
CA2521612C (en) 2012-02-07
CN1774414A (zh) 2006-05-17
NO20055331D0 (no) 2005-11-11
KR101091324B1 (ko) 2011-12-07
ZA200508247B (en) 2007-03-28
CA2521612A1 (en) 2004-10-21
EP1615874B1 (en) 2013-12-25
JP2006526048A (ja) 2006-11-16
US7491836B2 (en) 2009-02-17
AU2004228602B2 (en) 2007-06-14
KR20060004937A (ko) 2006-01-16
NZ542752A (en) 2007-05-31
AU2004228602A1 (en) 2004-10-21
EP1615874A1 (en) 2006-01-18
US20060287542A1 (en) 2006-12-21
ES2445821T3 (es) 2014-03-05
SE0301119D0 (sv) 2003-04-14
IL171058A (en) 2011-04-28

Similar Documents

Publication Publication Date Title
BR9916790A (pt) Uso de um composto, composto, processo para amanufatura do mesmo, composição farmacêtica, e,método para produzir um efeito de dano vascularem um animal de sangue quente
PH12014500367A1 (en) Alkyl lactyllactates and processes of making the same
NO20055331L (no) Nye ikke-ioniske overflateaktive stoffer for a opplose darlig loselige molekyler
BR0109251A (pt) Formulação agrotécnica, e, uso de um ciclo-hexanopolicarboxato de di(isononila)
AP1422A (en) 6.Alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl)oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent.
ES2149340T3 (es) Disacaridos de glucosamina, metodo para su preparacion, composicion farmaceutica que los comprende, y su uso.
AR028693A1 (es) Composiciones de éteres de monoalquil glicerol estables para almacenamiento
BRPI0411197A (pt) éter de celulose, processo para produzì-lo, e composições para cuidado pessoal e para cuidado dos cabelos ou pele
BR0214142A (pt) Derivados e intermediários de n-adamantilmetila como composições farmacêuticas e processos para sua preparação
BR0014285A (pt) Adjuvantes compreendendo um éster ou éter de alquila de polioxietileno e pelo menos um tensoativo não-iÈnico
BRPI0401642A (pt) Composição umectante para a pele
MY154966A (en) Low foaming cleaner
ES2163462T3 (es) Composicion detergente para superficie dura.
DK1230330T3 (da) Anvendelse af fedtsyresalte af alkoxylerede oligoaminer som smöreevneforbedrende midler til mineralprodukter
UY29380A1 (es) Composiciones limpiadoras que proporcionan remoción de grasa y entrega de fragancia.
ATE251382T1 (de) Dithiocarbamat-flüssigformulierungen
AU7704591A (en) Novel derivatives of endogenous mediators, their salts, method of preparation, applications and compositions in which they are present
AR063894A1 (es) Uso de un acido indazolmetoxialcanoico para preparar una composicion farmaceutica
HRP20030907B1 (en) Pharmaceutical composition based on macrolides for topical application in ophthalmology
BR0009214A (pt) Composições aquosas estáveis contendo umcomposto de silìcio
BRPI0409225A (pt) processo para por em evidência a atividade de drenagem de um tratamento cosmético e/ou dermo-cosmético, composição cosmética e utilização de um ativo lipolìtico
DE69809791D1 (de) Schwindungreduzierendes mittel für zementzusammensetzungen
BR0112338A (pt) Composto, composição farmacêutica, e, uso de um composto
BR0214241A (pt) Método para preparar uma composição compreendendo lipossomas contendo anestésico tópico e composição obtida
BRPI0012329B8 (pt) derivados de benzofurano, processo para sua preparação e uso dos mesmos.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.